Role of fibrocytes in atherogenesis

Fibrocytes: New Insights into Tissue Repair and Systemic Fibrosis

Volumn , Issue , 2007, Pages 175-194

  Medbury, Heather ^a  

^a UNIVERSITY OF SYDNEY   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 84967372616     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1142/9789812706690_0010     Document Type: Chapter

References (79)

1. Ross R. (1999) Atherosclerosis - an inflammatory disease. N Engl J Med 340: 115-126.
2. Traub O, Berk BC. (1998) Laminar shear stress: mechanisms by which endothelial cells transduce an atheroprotective force. Arterioscler Thromb Vasc Biol 18: 677-685.
3. Davies MJ. (1996) Stability and instability: two faces of coronary atherosclerosis. The Paul Dudley White Lecture 1995. Circulation 94: 2013-2020.
4. Ross R. (1995) Cell biology of atherosclerosis. Annu Rev Physiol 57: 791-804.
5. Stary HC, Chandler AB, Glagov S, et al. (1994) A definition of initial, fatty streak, and intermediate lesions of atherosclerosis. Areport from the Committee on Vascular Lesions of the Council on Arteriosclerosis, American Heart Association. Arterioscler Thromb 14: 840-856.
6. Stary HC, Chandler AB, Dinsmore RE, et al. (1995) A definition of advanced types of atherosclerotic lesions and a histological classification of atherosclerosis. A report from the Committee on Vascular Lesions of the Council on Arteriosclerosis, American Heart Association. Arterioscler Thromb Vasc Biol 15: 1512-1531.
7. Munro JM, Cotran RS. (1988) The pathogenesis of atherosclerosis: Atherogenesis and inflammation. Lab Invest 58: 249-261.
8. Ross R, Glomset JA. (1973) Atherosclerosis and the arterial smooth muscle cell: proliferation of smooth muscle is a key event in the genesis of the lesions of atherosclerosis. Science 180: 1332-1339.
9. Singer AJ, Clark RA. (1999) Cutaneous wound healing. N Engl J Med 341: 738-746.
10. Hart J. (2002) Inflammation. 2: its role in the healing of chronic wounds. J Wound Care 11: 245-249.
11. Pasterkamp G, de Kleijn DP, Borst C. (2000) Arterial remodeling in atherosclerosis, restenosis and after alteration of blood flow: potential mechanisms and clinical implications. Cardiovasc Res 45: 843-852.
12. Bucala R, Spiegel LA, Chesney J, et al. (1994) Circulating fibrocytes define a new leukocyte subpopulation that mediates tissue repair. Mol Med 1: 71-81.
13. Grainger DJ. (2004) Transforming growth factor beta and atherosclerosis: so far, so good for the protective cytokine hypothesis. Arterioscler Thromb Vasc Biol 24: 399-404.
14. Orlandi A, Bochaton-Piallat ML, Gabbiani G, Spagnoli LG. (2006) Aging, smooth muscle cells and vascular pathobiology: implications for atherosclerosis. Atherosclerosis (in press).
15. Orlandi A, Marcellini M, Spagnoli LG. (2000) Aging influences development and progression of early aortic atherosclerotic lesions in cholesterol-fed rabbits. Arterioscler Thromb Vasc Biol 20: 1123-1136.
16. Zaman AG, Helft G, Worthley SG, Badimon JJ. (2000) The role of plaque rupture and thrombosis in coronary artery disease. Atherosclerosis 149: 251-266.
17. Gawaz M, Neumann FJ, Dickfeld T, et al. (1997) Vitronectin receptor (alpha(v)beta3) mediates platelet adhesion to the luminal aspect of endothelial cells: implications for reperfusion in acute myocardial infarction. Circulation 96: 1809-1818.
18. Massberg S, Enders G, Leiderer R, et al. (1998) Platelet-endothelial cell interactions during ischemia/reperfusion: the role of P-selectin. Blood 92: 507-515.
19. Massberg S, Brand K, Gruner S, et al. (2002) A critical role of platelet adhesion in the initiation of atherosclerotic lesion formation. J Exp Med 196: 887-896.
20. Yla-Herttuala S, Lipton BA, Rosenfeld ME, et al. (1991) Expression of monocyte chemoattractant protein 1 in macrophage-rich areas of human and rabbit atherosclerotic lesions. Proc Natl Acad Sci USA 88: 5252-5256.
21. Nelken NA, Coughlin SR, Gordon D, Wilcox JN. (1991) Monocyte chemoattractant protein-1 in human atheromatous plaques. J Clin Invest 88: 1121-1127.
22. Han J, Hajjar DP, Febbraio M, Nicholson AC. (1997) Native and modified low density lipoproteins increase the functional expression of the macrophage class B scavenger receptor, CD36. J Biol Chem 272: 21654-21659.
23. Hegyi L, Skepper JN, Cary NR, Mitchinson MJ. (1996) Foam cell apoptosis and the development of the lipid core of human atherosclerosis. J Pathol 180: 423-429.
24. Raines EW, Ross R. (1993) Smooth muscle cells and the pathogenesis of the lesions of atherosclerosis. Br Heart J 69: S30-S37.
25. Hart J. (2002) Inflammation. 1: its role in the healing of acute wounds. J Wound Care 11: 205-209.
26. Leonarduzzi G, Sevanian A, Sottero B, et al. (2001) Up-regulation of the fibrogenic cytokine TGF-beta1 by oxysterols: a mechanistic link between cholesterol and atherosclerosis. Faseb J 15: 1619-1621.
27. Grainger DJ, Kemp PR, Liu AC, et al. (1994) Activation of transforming growth factor-beta is inhibited in transgenic apolipoprotein(a) mice. Nature 370: 460-462.
28. Ignotz RA, Massague J. (1986) Transforming growth factor-beta stimulates the expression of fibronectin and collagen and their incorporation into the extracellular matrix. J Biol Chem 261: 4337-4345.
29. Simper D, Stalboerger PG, Panetta CJ, et al. (2002) Smooth muscle progenitor cells in human blood. Circulation 106: 1199-1204.
30. Gordon D, Reidy MA, Benditt EP, Schwartz SM. (1990) Cell proliferation in human coronary arteries. Proc Natl Acad Sci USA 87: 4600-4604.
31. Lutgens E, de Muinck ED, Kitslaar PJ, et al. (1999) Biphasic pattern of cell turnover characterizes the progression from fatty streaks to ruptured human atherosclerotic plaques. Cardiovasc Res 41: 473-479.
32. Schwartz SM. (1999) The intima: a new soil. Circ Res 85: 877-879.
33. Sata M. (2003) Circulating vascular progenitor cells contribute to vascular repair, remodeling, and lesion formation. Trends Cardiovasc Med 13: 249-253.
34. Caplice NM, Bunch TJ, Stalboerger PG, et al. (2003) Smooth muscle cells in human coronary atherosclerosis can originate from cells administered at marrow transplantation. Proc Natl Acad Sci USA 100: 4754-4759.
35. Sata M, Saiura A, Kunisato A, et al. (2002) Hematopoietic stem cells differentiate into vascular cells that participate in the pathogenesis of atherosclerosis. Nat Med 8: 403-409.
36. Abe R, Donnelly SC, Peng T, et al. (2001) Peripheral blood fibrocytes: differentiation pathway and migration to wound sites. J Immunol 166: 7556-7562.
37. Quan TE, Cowper S, Wu SP, et al. (2004) Circulating fibrocytes: Collagen-secreting cells of the peripheral blood. Int J Biochem Cell Biol 36: 598-606.
38. Mori L, Bellini A, Stacey MA, et al. (2005) Fibrocytes contribute to the myofibroblast population in wounded skin and originate from the bone marrow. Exp Cell Res 304: 81-90.
39. Lutgens E, Gijbels M, Smook M, et al. (2002) Transforming growth factor-beta mediates balance between inflammation and fibrosis during plaque progression. Arterioscler Thromb Vasc Biol 22: 975-982.
40. Kakolyris S, Karakitsos P, Tzardi M, Agapitos E. (1995) Immunohistochemical detection of fibronectin in early and advanced atherosclerosis. In Vivo 9: 35-40.
41. Stenman S, von Smitten K, Vaheri A. (1980) Fibronectin and atherosclerosis. Acta Med Scand Suppl 642: 165-170.
42. Moore BB, Kolodsick JE, Thannickal VJ, et al. (2005) CCR2-mediated recruitment of fibrocytes to the alveolar space after fibrotic injury. Am J Pathol 166: 675-684.
43. Fletcher JP, Vasista A, Guiffre AK, Medbury HJ. (2004) Fibrocytes in atherosclerosis. Circulation 110: 78.
44. Medbury HJ, Guiffre AK, Williams M, et al. (2006) The opposing roles of monocytes in atherosclerosis. Submitted.
45. Prockop DJ, Sieron AL, Li SW. (1998) Procollagen N-proteinase and procollagen C-proteinase. Two unusual metalloproteinases that are essential for procollagen processing probably have important roles in development and cell signaling. Matrix Biol 16: 399-408.
46. Yang L, Scott PG, Dodd C, et al. (2005) Identification of fibrocytes in postburn hypertrophic scar. Wound Repair Regen 13: 398-404.
47. McDonald JA, Kelley DG, Broekelmann TJ. (1982) Role of fibronectin in collagen deposition: Fab’ to the gelatin-binding domain of fibronectin inhibits both fibronectin and collagen organization in fibroblast extracellular matrix. J Cell Biol 92: 485-492.
48. Schmidt M, Sun G, Stacey MA, et al. (2003) Identification of circulating fibrocytes as precursors of bronchial myofibroblasts in asthma. J Immunol 171: 380-389.
49. Mach F, Schonbeck U, Bonnefoy JY, et al. (1997) Activation of monocyte/macrophage functions related to acute atheroma complication by ligation of CD40: induction of collagenase, stromelysin, and tissue factor. Circulation 96: 396-399.
50. Davies MJ. (2000) Pathophysiology of acute coronary syndromes. Indian Heart J 52: 473-479.
51. Diegelmann RF, Evans MC. (2004) Wound healing: an overview of acute, fibrotic and delayed healing. Front Biosci 9: 283-289.
52. Varcoe RL, Mikhail M, Guiffre AK, et al. (2006) The role of the fibrocyte in intimal hyperplasia. J Thromb Haemost 4: 1125-1133.
53. Blakytny R, Ludlow A, Martin GE, et al. (2004) Latent TGF-beta1 activation by platelets. J Cell Physiol 199: 67-76.
54. Burke AP, Kolodgie FD, Farb A, et al. (2001) Healed plaque ruptures and sudden coronary death: evidence that subclinical rupture has a role in plaque progression. Circulation 103: 934-940.
55. Braganza DM, Bennett MR. (2001) New insights into atherosclerotic plaque rupture. Postgrad Med J 77: 94-98.
56. Khalil N. (1999) TGF-beta: from latent to active. Microbes Infect 1: 1255-1263.
57. Grainger DJ, Kemp, PR, Metcalfe JC. (1995) The serum concentration of active transforming growth factor-beta is severely depressed in advanced atherosclerosis. Nat Med 1: 74-79.
58. Grainger DJ, Byrne CD, Witchell CM, Metcalfe JC. (1997) Transforming growth factor beta is sequestered into an inactive pool by lipoproteins. J Lipid Res 38: 2344-2352.
59. Martin-Paredero V, Vadillo J, Diaz J, et al. (1998) Fibrinogen and fibrinolysis in blood and in the arterial wall: its role in advanced atherosclerotic disease. Cardiovasc Surg 6: 457-462.
60. Mallat Z, Gojova A, Marchiol-Fournigault C, et al. (2001) Inhibition of transforming growth factor-beta signaling accelerates atherosclerosis and induces an unstable plaque phenotype in mice. Circ Res 89: 930-934.
61. Gamble JR, Khew-Goodall Y, Vadas MA. (1993) Transforming growth factor-beta inhibits E-selectin expression on human endothelial cells. J Immunol 150: 4494-4503.
62. Bogdan C, Nathan C. (1993) Modulation of macrophage function by transforming growth factor beta, interleukin-4, and interleukin-10. Ann N Y Acad Sci 685: 713-739.
63. Draude G, Lorenz RL. (2000) TGF-beta1downregulates CD36and scavenger receptor Abut upregulates LOX-1 in human macrophages. Am J Physiol Heart Circ Physiol 278: H1042-H1048.
64. Gojova A, Brun V, Esposito B, et al. (2003) Specific abrogation of transforming growth factor-beta signaling in T cells alters atherosclerotic lesion size and composition in mice. Blood 102: 4052-4058.
65. Robertson AK, Rudling M, Zhou X, et al. (2003) Disruption of TGFbeta signaling in T cells accelerates atherosclerosis. J Clin Invest 112: 1342-1350.
66. Hall MC, Young DA, Waters JG, et al. (2003) The comparative role of activator protein 1 and Smad factors in the regulation of Timp-1 and MMP-1 gene expression by transforming growth factor-beta 1. J Biol Chem 278: 10304-10313.
67. Strassmann G, Cone JL, Arthur PM, et al. (1989) Effect of plateletderived transforming growth factor (TGF) type beta 1 on murine inflammatory mononuclear phagocytes: increased fibronectin production. Cell Immunol 121: 306-316.
68. Baccante G, Mincione G, Di Marcantonio MC, et al. (2004) Pravastatin up-regulates transforming growth factor-beta1 in THP-1 human macrophages: effect on scavenger receptor class Aexpression. Biochem Biophys Res Commun 314: 704-710.
69. Falk E, Shah PK, Fuster V. (1995) Coronary plaque disruption. Circulation 92: 657-671.
70. Davies MJ, Richardson PD, Woolf N, et al. (1993) Risk of thrombosis in human atherosclerotic plaques: role of extracellular lipid, macrophage, and smooth muscle cell content. Br Heart J 69: 377-381.
71. Felton CV, Crook D, Davies MJ, Oliver MF. (1997) Relation of plaque lipid composition and morphology to the stability of human aortic plaques. Arterioscler Thromb Vasc Biol 17: 1337-1345.
72. Pilling D, Buckley CD, Salmon M, Gomer RH. (2003) Inhibition of fibrocyte differentiation by serum amyloid P. J Immunol 171: 5537-5546.
73. Kuwana M, Okazaki Y, Kodama H, et al. (2003) Human circulating CD14+ monocytes as a source of progenitors that exhibit mesenchymal cell differentiation. J Leukoc Biol 74: 833-845.
74. Zhao Y, Glesne D, Huberman E. (2003) A human peripheral blood monocyte-derived subset acts as pluripotent stem cells. Proc Natl Acad Sci USA 100: 2426-2431.
75. Huzoor A, Ardlie NG. (1977) Platelet activation in haemostasis: role of thrombin and other clotting factors in platelet-collagen interaction. Haemostasis 6: 59-71.
76. Davies MG, Hagen PO. (1994) Pathobiology of intimal hyperplasia. Br J Surg 81: 1254-1269.
77. Shi Y, O’Brien JE, Fard A, et al. (1996) Adventitial myofibroblasts contribute to neointimal formation in injured porcine coronary arteries. Circulation 94: 1655-1664.
78. Campbell JH, Han, CL, Campbell GR. (2001) Neointimal formation by circulating bone marrow cells. Ann N Y Acad Sci 947: 18-24; discussion 24-25.
79. Han CI, Campbell GR, Campbell JH. (2001) Circulating bone marrow cells can contribute to neointimal formation. J Vasc Res 38: 113-119.